Device Trial Radar · NCT06374342
Bone Substitutes Outcomes - Post Market Follow-up
Last checked: Nov 20, 2026Latest source record: Sep 9, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
425
Planned (sponsor's estimate)
Start
Sep 16, 2021
Primary completion
Sep 16, 2026
Study completion Sep 30, 2032
Sponsor
- Lead sponsor
- TeknimedNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 18, 2024
Design
- Study type
- Observational
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Post-Market Clinical Follow-Up (PMCF) Study to collect clinical data on safety and performance of all TEKNIMED Bone Substitute range of products: CERAFORM, TRIHA+, NANOGEL, and all their private labels. TEKNIMED bone substitutes are legacy products, some marketed for more than 20 years. Their performance and safety have already been demonstrated by Post-Market Surveillance and previous clinical studies. The current Post-Market Clinical Follow-Up study aims to confirm these claims by collecting data in a "real-life" setting. The study is a retrospective and prospective global, single arm, non-controlled, multicentric, prospective observational study. Patients will be followed as per local standard medical care of the sites.
Conditions
- Bone Resorption
Interventions
Bone defectDevice
Bone grafting is a procedure where damaged bones can be repaired or rebuilt using transplanted bone from another source. Sources for transplant bone include the patient (autograft), a cadaver (allograft) or synthetic bone.
Spine fusionDevice
Spinal fusion is a surgery procedure that reinforces your back structure and stability by linking two vertebrae together
Cage fillingDevice
Intervertebral fusion with cages is a surgical procedure used to stabilize the spine by fusing adjacent vertebrae. The cages, typically made of materials like titanium or plastic, and pre-filled with bone graft substitutes are placed between the vertebrae to maintain the proper spacing and alignment.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Successful bone repairTime frame: 24 months
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Pôle Rachis Hôpital Privé d'Eure et Loir
Mainvilliers, Eure et Loir, France · Recruiting
Hôpital Joseph Ducuing
Toulouse, Haute Garonne, France · Recruiting
Clinique Médipole Garonne
Toulouse, Haute Garonne, France · Recruiting
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.